HealthLynked Corp.
HLYK
$0.0287
-$0.0005-1.71%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -31.49% | -57.55% | -53.28% | -42.69% | -33.58% |
| Total Other Revenue | -420.41% | 74.19% | -57.29% | -53.37% | -57.02% |
| Total Revenue | -33.54% | -55.71% | -53.33% | -42.79% | -33.78% |
| Cost of Revenue | -27.51% | -40.80% | -42.30% | -38.36% | -39.02% |
| Gross Profit | -46.22% | -79.07% | -66.69% | -48.58% | -19.16% |
| SG&A Expenses | -40.52% | -17.70% | 3.33% | -9.45% | 2.18% |
| Depreciation & Amortization | -67.84% | -5.38% | -3.40% | -1.82% | -57.38% |
| Other Operating Expenses | -17.28% | -33.94% | -39.77% | -22.69% | -39.38% |
| Total Operating Expenses | -33.07% | -29.67% | -25.06% | -22.39% | -27.29% |
| Operating Income | 32.67% | -10.45% | -35.26% | -11.49% | 20.79% |
| Income Before Tax | 4.32% | -1,122.49% | -55.75% | -17.82% | 68.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.32% | -1,122.49% | -55.75% | -17.82% | 68.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.32% | -1,028.13% | -53.50% | -195.58% | 69.92% |
| EBIT | 32.67% | -10.45% | -35.26% | -11.49% | 20.79% |
| EBITDA | 33.36% | -11.17% | -36.93% | -11.99% | -63.77% |
| EPS Basic | 8.33% | -900.00% | -41.03% | -187.50% | 72.09% |
| Normalized Basic EPS | -7.14% | -20.83% | -43.48% | -7.41% | 22.22% |
| EPS Diluted | 8.33% | -1,328.57% | -156.41% | -187.50% | 72.09% |
| Normalized Diluted EPS | -7.14% | -20.83% | -43.48% | -7.41% | 22.22% |
| Average Basic Shares Outstanding | 4.79% | 6.19% | 8.46% | 9.08% | 6.05% |
| Average Diluted Shares Outstanding | 4.79% | 6.19% | 8.46% | 9.08% | 6.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |